Eledon Pharmaceuticals In... (ELDN)

AI Score

Unlock

3.15

-0.16 (-4.83%)

At close: Apr 03, 2025, 3:59 PM

3.25

3.02%

After-hours: Apr 03, 2025, 07:55 PM EDT

Eledon Pharmaceuticals Balance Sheet Statement

Chart Mode

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Cash & Equivalents	20.55M	4.61M	56.41M	84.83M	114.19M	8.79M	12.97M	17.23M	23.22M	24.02M	105.26M	31.75M	11.69M
Short-Term Investments	119.63M	46.49M	n/a	n/a	n/a	n/a	n/a	n/a	4.17M	39.93M	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	270K	n/a	n/a	n/a
Other Long-Term Assets	363K	186K	150K	400K	383K	639K	869K	n/a	120K	45K	200K	80K	20K
Receivables	n/a	n/a	n/a	n/a	110K	245K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	1.29M	881K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	3.55M	90K	28K	34K	38K	54K	630K	88K	47K	3.21M	2.25M	n/a	n/a
Total Current Assets	143.73M	56.13M	59.52M	88.35M	115.63M	9.97M	14.28M	19M	29.54M	67.17M	107.51M	32.18M	11.93M
Property-Plant & Equipment	926K	365K	739K	768K	138K	321K	14K	25K	98K	489K	33K	29K	16K
Goodwill & Intangibles	32.39M	32.39M	32.39M	81.03M	81.03M	n/a	1.87M	1.87M	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	33.67M	32.94M	33.27M	82.2M	81.56M	960K	2.75M	1.89M	218K	804K	233K	109K	36K
Total Assets	177.41M	89.07M	92.79M	170.55M	197.19M	10.93M	17.03M	20.89M	29.76M	67.97M	107.74M	32.29M	11.96M
Account Payables	5.83M	967K	2.2M	1.81M	1.37M	329K	689K	418K	338K	1.21M	765K	5K	764K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-3.45M	n/a	n/a	n/a	n/a
Short-Term Debt	314K	n/a	363K	369K	144K	n/a	n/a	n/a	3.45M	n/a	n/a	n/a	n/a
Other Current Liabilities	1.6M	2M	1.64M	1.15M	798K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Liabilities	11.58M	3.9M	6.47M	4.4M	2.48M	1.32M	2.53M	1.44M	2.82M	6.16M	4.24M	2.21M	2.02M
Long-Term Debt	640K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	44.87M	76.21M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	88K	n/a	85.34M	49.84M
Total Long-Term Liabilities	47.69M	77.96M	2.13M	2.15M	4.11M	144K	1.84M	1.02M	84K	88K	n/a	85.34M	49.84M
Total Liabilities	59.27M	81.86M	8.61M	6.55M	6.59M	1.47M	2.53M	1.44M	2.9M	6.25M	4.24M	87.55M	51.86M
Total Debt	954K	383K	746K	769K	144K	324K	n/a	n/a	3.45M	n/a	n/a	n/a	n/a
Common Stock	60K	24K	14K	14K	15K	13K	9K	7K	23K	23K	22K	n/a	n/a
Retained Earnings	-355.59M	-319.4M	-202.87M	-114.9M	-80.39M	-57.58M	-41.57M	-27.51M	-169.4M	-131.44M	-86.35M	-63.05M	-47.33M
Comprehensive Income	26K	n/a	0.00	n/a	0.00	-0.00	n/a	n/a	-1K	-55K	-58K	-43K	-51K
Shareholders Equity	118.14M	7.21M	84.18M	164M	190.6M	9.46M	14.49M	19.45M	26.86M	61.72M	103.5M	-55.27M	-39.9M
Total Investments	119.63M	46.49M	n/a	n/a	n/a	n/a	n/a	n/a	4.17M	39.93M	n/a	n/a	n/a